Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Clinical Implications of Germline Predisposition Gene Variants in Patients with Refractory or Relapsed B Acute Lymphoblastic Leukemia

Zhao Defeng, Tong Wu, Chunrong Tong, Lin Yuehui, Qinlong Zheng

Blood (2023) 142 (Supplement 1): 1612.

https://doi.org/10.1182/blood-2023-181512

Published: 2023

Journal Articles

T Cell Selection Is Not Helpful for Therapeutic Efficacy of CART19 in Relapsed or Refractory B-ALL Patients with Peripheral Blood Leukemia Burden at Time of Apheresis

Biping Deng, Zhaoli Liu, Jing PAN, Shuangyou Liu, Xiaoming Qu, Yu'e Zhang, Lingli Zhang, Ming Ma, Zhongxin Zhang, Xinjian Yu, Qinlong Zheng, Chunrong Tong

Blood (2023) 142 (Supplement 1): 6943.

https://doi.org/10.1182/blood-2023-180359

Published: 2023

Journal Articles

The Efficacy and Safety of Olverembatinib Combined with Monoclonal Antibodies As Salvage Therapy for RR B ALL with ABL1 Fusion Gene Positive

Yuehui Lin, Tong Wu, Dan Liu, Chunrong Tong

Blood (2023) 142 (Supplement 1): 5896.

https://doi.org/10.1182/blood-2023-186153

Published: 2023

Journal Articles

Sustained Remission and Decreased Severity of CAR T-Cell Related Adverse Events: A Pivotal Study Report of CNCT19 (inaticabtagene autoleucel) Treatment in Adult Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-Cell ALL) in China

Ying Wang, Xudong Wei, Dongmei Yan, Cheng Zhang, Hongsheng Zhou, Chunrong Tong, Heng Mei, Jie Jin, Ting Niu, Aibin Liang, Jienan Ren, Yiping Deng, Wei Jin, Yi Feng, Lin Shi, Yongzeng Wang, Changting Haudenschild, Lulu Lv, Jianxiang Wang

Blood (2022) 140 (Supplement 1): 1598–1600.

https://doi.org/10.1182/blood-2022-165002

Published: 2022

Journal Articles

Influence of Inherited and Acquired Hematological and Immunological Gene Variants on the Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies

Zhihui Li, Yongqiang Zhao, MD, Yanzhi Song, MD, Caiyan Zhang, PhD, Qinlong Zheng, PhD, Chunrong Tong, Tong Wu, MD

Blood (2020) 136 (Supplement 1): 46–47.

https://doi.org/10.1182/blood-2020-139220

Published: 2020

Journal Articles

Sequential CD19-22 CAR T therapy induces sustained remission in children with r/r B-ALL

Jing Pan, Shiyu Zuo, Biping Deng, Xiuwen Xu, Chuo Li, Qinlong Zheng, Zhuojun Ling, Weiliang Song, Jinlong Xu, Jiajia Duan, Zelin Wang, Xinjian Yu, Alex H. Chang, Xiaoming Feng, Chunrong Tong

Blood (2020) 135 (5): 387–391.

https://doi.org/10.1182/blood.2019003293

Published: 2020

Includes: Supplemental data

Journal Articles

Potential Influence of Hematological or Immunological Hereditary Predisposition Genes on the Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies

Zhihui Li, Qinlong Zheng, Yongqiang Zhao, Yanzhi Song, Fan Yang, Min Jiang, Chunrong Tong, Tong Wu, MD

Blood (2019) 134 (Supplement_1): 2037.

https://doi.org/10.1182/blood-2019-126339

Published: 2019

Journal Articles

Leukemia Burden in Peripheral Blood Has Negative Impact on CD19-CART Cell Culture and Its Clinical Efficacy in Patients with Refractory or Relapsed B Cell Acute Lymphoblastic Leukemia

Biping Deng, BS, MD, Jing Pan, Shuangyou Liu, Yuehui Lin, Zhaoli Liu, Yunlong Chen, Xiaoming Qu, Yu 'e Zhang, Zhongxin Zhang, Xuansha Niu, Ming Ma, Tong Wu, MD, Alex Hong Chang, Chunrong Tong

Blood (2019) 134 (Supplement_1): 1957.

https://doi.org/10.1182/blood-2019-126695

Published: 2019

Journal Articles

Corticosteroids Do Not Influence the Efficacy and Kinetics of CAR-T Cells for B-Cell Acute Lymphoblastic Leukemia

Shuangyou Liu, Biping Deng, BS, MD, Jing PAN, Zhichao Yin, Yuehui Lin, Zhuojun Ling, Tong Wu, MD, Zhiyong Gao, Yanzhi Song, Yongqiang Zhao, Chunrong Tong

Blood (2019) 134 (Supplement_1): 228.

https://doi.org/10.1182/blood-2019-123051

Published: 2019

Journal Articles

Allogeneic CAR-T Cell Therapy for Treatment of Relapse after Allo-HSCT in Patients with Refractory CML Lymphoid Blast Crisis: Significance of HLA Matched Donor/Patient Pair in the Safety/Efficacy of CAR-T Cell Therapy

Kai Sun, MD, Xuejun Zhang, MD, Zhen Wang, MD, Yuqing Chen, MD, Lei Zhang, MD, Wei Cheng, MD, Mingyue Shi, MD, Lei Huo, MD, Yanliang Bai, MD, Xiaona Niu, MD, Honggang Guo, MD, Jing Yang, MD, Chunrong Tong, MD, AlexH Chang, MD, PhD

Blood (2018) 132 (Supplement 1): 4275.

https://doi.org/10.1182/blood-2018-99-115768

Published: 2018

Journal Articles

Sequential CD19- and CD22-CART Cell Therapies for Relapsed B-Cell Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

Shuangyou Liu, Biping Deng, Yuehui Lin, Zhichao Yin, Jing Pan, Tong Wu, Zhiyong Gao, Yanzhi Song, Yongqiang Zhao, Chunrong Tong

Blood (2018) 132 (Supplement 1): 2126.

https://doi.org/10.1182/blood-2018-99-111856

Published: 2018

Journal Articles

Immunodeficiency Caused Byheterozygous RAG1 Gene Mutation in a Boy Manifested As Severe Granulomatous Diseases and Eosinophilia: A Case Report

Jing PAN, MD, Min Xiong, Jingjing Wang, Shan Wang, Zhuojun Ling, Jinlong Xu, Jiajia Duan, Gen Wang, Tong Wu, MD PhD, Chunrong Tong

Blood (2017) 130 (Supplement 1): 4828.

https://doi.org/10.1182/blood.V130.Suppl_1.4828.4828

Published: 2017

Journal Articles

Safety and Efficacy of Low Dose CD19 Targeted Chimeric Antigen Receptor T (CAR-T) Cell Immunotherapy in 47 Cases with Relapsed Refractory B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Biping Deng, MD, Alex Hongsheng Chang, Professor, Junfang Yang, MD, Jing Pan, MD, Xian Zhang, PhD, Yuehui Lin, MD, Yanan Wu, MD, Zhenling Deng, PhD, Peihua Lu, MD, Tong Wu, MD, Zhaoli Liu, Bachelor, Yu'e Zhang, Bachelor, Chunrong Tong, MD

Blood (2016) 128 (22): 649.

https://doi.org/10.1182/blood.V128.22.649.649

Published: 2016

Journal Articles

ASXL1-Mutated Donor HSCs Evolved into FLT3-ITD Positive AML in the Unrelated Donor and FLT3-ITD Negative AML in the Recipient after Transplant

Zhongwen Liu, MD, Hongxing Liu, MD, Yanli Zhang, MD, Dai Kong, MD, Jie Shi, MD, Yin Zhang, MD, Meiying Wen, Yongping Song, MD PhD, Chunrong Tong, MD, Mingyi Chen, MD PhD, William J. Murphy, PhD, Kai Sun, MD PhD

Blood (2015) 126 (23): 5403.

https://doi.org/10.1182/blood.V126.23.5403.5403

Published: 2015

Journal Articles

Mutaome Profiling and Retrospective Mutaome Profiling Using Archived Bone Marrow Smear In AML

Hongxing Liu, MD, Fang Wang, MD, Wen Teng, Yuehui Lin, MD, Junfang Yang, MD., Xian Zhang, Qing Yin, Xue Chen, Ping Zhu, MD, Chunrong Tong, MD

Blood (2013) 122 (21): 4983.

https://doi.org/10.1182/blood.V122.21.4983.4983

Published: 2013

Journal Articles

Identification of a De Novo UNC13D L1000P Mutation in a Familial Hemophagocytic Lymphohistiocytosis Patient

Hongxing Liu, MD, Fang Wang, MD, Juan Zhu, MD, Hui Wang, MD, Ping Wu, MD, Wen Teng, Xu Han, Jianfeng Zhang, Ping Zhu, MD, Tong Wu, MD, Chunrong Tong, MD

Blood (2011) 118 (21): 4927.

https://doi.org/10.1182/blood.V118.21.4927.4927

Published: 2011

Journal Articles

Three Novel Clonal Non-Characteristic Chromosome Aberrations in Acute Myeloid Leukemia Resembling Acute Promyelocytic Leukemia

Hongxing Liu, MD, Wenjun Tian, MD, Fang Wang, MD, Juan Zhu, MD, Wen Teng, Hui Wang, MD, Tong Wang, MD, Ping Wu, MD, Ping Zhu, MD, Tong Wu, MD, Chunrong Tong, MD

Blood (2011) 118 (21): 4912.

https://doi.org/10.1182/blood.V118.21.4912.4912

Published: 2011

Journal Articles

High doses of mother's lymphocyte infusion to treat EBV-positive T-cell lymphoproliferative disorders in childhood

Qian Wang, Hongxing Liu, Xian Zhang, Qian Liu, Yanping Xing, Xiaoge Zhou, Chunrong Tong, Ping Zhu

Blood (2010) 116 (26): 5941–5947.

https://doi.org/10.1182/blood-2010-01-262311

Published: 2010

Includes: Supplemental data

Journal Articles

Clonal Evolution of BCR-ABL1 Kinase Domain Mutation In Tyrosine Kinase Inhibitor Treatment Patient

Hongxing Liu, Ping Zhu, MD, Chunrong Tong, MD, Yanli Zhao, Peng Cai, Juan Zhu, Fang Wang, Jiangying Gu, MD, Jianjun Xie, MD, Xian Zhang, MD, Dao-Pei Lu, MD

Blood (2010) 116 (21): 597.

https://doi.org/10.1182/blood.V116.21.597.597

Published: 2010

Journal Articles

Predictable Recurrence by Regular Monitoring Minimal Residual Disease with Flowcytometry In the Patients with Both AML and ALL: A Single-Center Study of 158 Cases.

Chunrong Tong, MD, Junfang Yang, MD, Yuehui Lin, MD, Xinhong Fei, MD, Jie Zhao, MD, Xian Zhang, MD, Jiangying Gu, MD, Tong Wu, MD, Dao-Pei Lu, MD, Hui Wang, MD

Blood (2010) 116 (21): 1661.

https://doi.org/10.1182/blood.V116.21.1661.1661

Published: 2010

NARROW

Clinical Implications of Germline Predisposition Gene Variants in Patients with Refractory or Relapsed B Acute Lymphoblastic Leukemia

T Cell Selection Is Not Helpful for Therapeutic Efficacy of CART19 in Relapsed or Refractory B-ALL Patients with Peripheral Blood Leukemia Burden at Time of Apheresis

The Efficacy and Safety of Olverembatinib Combined with Monoclonal Antibodies As Salvage Therapy for RR B ALL with ABL1 Fusion Gene Positive

Sustained Remission and Decreased Severity of CAR T-Cell Related Adverse Events: A Pivotal Study Report of CNCT19 (inaticabtagene autoleucel) Treatment in Adult Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-Cell ALL) in China

Influence of Inherited and Acquired Hematological and Immunological Gene Variants on the Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies

Sequential CD19-22 CAR T therapy induces sustained remission in children with r/r B-ALL

Potential Influence of Hematological or Immunological Hereditary Predisposition Genes on the Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies

Leukemia Burden in Peripheral Blood Has Negative Impact on CD19-CART Cell Culture and Its Clinical Efficacy in Patients with Refractory or Relapsed B Cell Acute Lymphoblastic Leukemia

Corticosteroids Do Not Influence the Efficacy and Kinetics of CAR-T Cells for B-Cell Acute Lymphoblastic Leukemia

Allogeneic CAR-T Cell Therapy for Treatment of Relapse after Allo-HSCT in Patients with Refractory CML Lymphoid Blast Crisis: Significance of HLA Matched Donor/Patient Pair in the Safety/Efficacy of CAR-T Cell Therapy

Sequential CD19- and CD22-CART Cell Therapies for Relapsed B-Cell Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

Immunodeficiency Caused Byheterozygous RAG1 Gene Mutation in a Boy Manifested As Severe Granulomatous Diseases and Eosinophilia: A Case Report

Safety and Efficacy of Low Dose CD19 Targeted Chimeric Antigen Receptor T (CAR-T) Cell Immunotherapy in 47 Cases with Relapsed Refractory B-Cell Acute Lymphoblastic Leukemia (B-ALL)

ASXL1-Mutated Donor HSCs Evolved into FLT3-ITD Positive AML in the Unrelated Donor and FLT3-ITD Negative AML in the Recipient after Transplant

Mutaome Profiling and Retrospective Mutaome Profiling Using Archived Bone Marrow Smear In AML

Identification of a De Novo UNC13D L1000P Mutation in a Familial Hemophagocytic Lymphohistiocytosis Patient

Three Novel Clonal Non-Characteristic Chromosome Aberrations in Acute Myeloid Leukemia Resembling Acute Promyelocytic Leukemia

High doses of mother's lymphocyte infusion to treat EBV-positive T-cell lymphoproliferative disorders in childhood

Clonal Evolution of BCR-ABL1 Kinase Domain Mutation In Tyrosine Kinase Inhibitor Treatment Patient

Predictable Recurrence by Regular Monitoring Minimal Residual Disease with Flowcytometry In the Patients with Both AML and ALL: A Single-Center Study of 158 Cases.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only